Antidote Treatment Nerve Agent Auto-Injector (ATNAA)
JustificationActive
This contract has been archived. It is preserved as a historical record.
Similar active opportunities:
This opportunity has closed
Similar active opportunities you might be interested in:
- ONRAB Oral Rabies Vaccine BaitsDue: March 30, 2026
- Notice of Intent to Sole Source BPA Call for Blood Bank Reagents for NMRTC SigonellaDue: April 1, 2026
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in PHILADELPHIA, PA
- Industry: Biological Product (except Diagnostic) Manufacturing
Contract Details
- Notice ID
- SPE2DP-26-D-0001
- Opportunity Type
- Justification
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE LOGISTICS AGENCY
- Office
- DLA TROOP SUPPORT
- Posted Date
- Wednesday, December 10, 2025
- Response Deadline
- Not specified
- PSC Code
- 6505
- Set-Aside
- Full & Open Competition
- Place of Performance
- PHILADELPHIA, PA, 19111
- Status
- Active
Description
In accordance with FAR 6.305(a), please see attachment for the redacted justification and approval for contract award to Meridian Medical Technologies, LLC for the manufacture and delivery of ATNAA.
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for biological product (except diagnostic) manufacturing in PHILADELPHIA, PA.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
- Knowledge Base
- Guides
- Glossary
- Q&A
- Documentation
- Blog
- For Small Business
- For Capture Teams
- Compare Platforms
- Services
- Workflow Automation
- Support
- Contact Us
© Copyright 2026 Gov Contract Finder.